Cyclacel Pharmaceuticals, Inc. - Common Stock, $0.001 par value (CYCC)

CUSIP: 23254L801

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 6 signals
Share change
-33,328
SEC-reported price per share
$2.11
Number of holders
12
Value change
-$90,802
Number of buys
4
Number of sells
3
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
1,584,707

Security key

23254L801

Report period

Q1 2024

Institutions

12

Top holders

10

Ownership snapshot

Top reported holders of CYCC - Cyclacel Pharmaceuticals, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Spiro George Rombotis
Disclosed value leader
Spiro George Rombotis
Comparable rows
0/15
Latest evidence
29 Jan 2024
3/4/5 13F Highest disclosed value: $227,601 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Spiro George Rombotis has the largest disclosed position value at $227.6K.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Spiro George Rombotis's linked filing trail.
Disclosed position value Top 5
Spiro George Rombotis $227.6K
Kenneth M. Ferguson $149K
Karin L. Walker $134.6K
Sam L. Barker $134K
Christopher S. Henney $130.7K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Spiro George Rombotis
3/4/5
President and CEO, Director
—
mixed-class rows
$227,601
184,728 shares
mixed-class rows
— 21 Dec 2023
Kenneth M. Ferguson
3/4/5
Director
—
mixed-class rows
$149,016
87,390 shares
mixed-class rows
— 30 Jun 2023
Karin L. Walker
3/4/5
Director
—
mixed-class rows
$134,596
83,040 shares
mixed-class rows
— 30 Jun 2023
Sam L. Barker
3/4/5
Director
—
mixed-class rows
$133,976
82,853 shares
mixed-class rows
— 30 Jun 2023
Christopher S. Henney
3/4/5
Director
—
mixed-class rows
$130,661
81,853 shares
mixed-class rows
— 30 Jun 2023
Robert J. Spiegel
3/4/5
Director
—
mixed-class rows
$130,661
81,853 shares
mixed-class rows
— 30 Jun 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
12
Shares
60,593
Rows available
12
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders
12
Q1 2024 holders
12
Holder diff
0
Investor Q1 2024 Shares Q1 2024 Shares Share Diff Share Chg % Q1 2024 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .